Company Filing History:
5 out of 5,469 
1 out of 1 Years Active: 2019-2025
Title: Xun Gui: Innovator in Antibody Research
Introduction
Xun Gui is a prominent inventor based in Houston, TX (US), known for his significant contributions to the field of antibody research. He holds a total of 5 patents, showcasing his innovative approach to medical science and therapeutic applications.
Latest Patents
One of Xun Gui's latest patents involves LILRB4 antibodies and their uses. This patent provides an isolated monoclonal antibody or an antigen-binding fragment that specifically binds to leukocyte immunoglobulin-like receptor 4 (LILRB4). The invention outlines various embodiments where the antibody modulates the activation of LILRB4, either activating or suppressing its function. Additionally, it describes methods for treating or ameliorating cancer effects by administering a therapeutically effective amount of the antibody or its fragments. Another aspect of his work includes methods for identifying LILRB-blocking antibodies, which can be used to treat cancer, autoimmune diseases, and inflammatory disorders.
Career Highlights
Xun Gui has worked with notable organizations, including the University of Texas System and Immune-Onc Therapeutics, Inc. His work in these institutions has allowed him to advance his research and contribute to the development of innovative therapies.
Collaborations
Throughout his career, Xun Gui has collaborated with esteemed colleagues such as Chengcheng Zhang and Mi Deng. These partnerships have further enriched his research and expanded the impact of his inventions.
Conclusion
Xun Gui's work in antibody research exemplifies the spirit of innovation in the medical field. His patents and collaborations highlight his commitment to advancing therapeutic solutions for various diseases.